Xeno Transplants Corp. operates as a bio-technology research and development company. The company is headquartered in Vancouver, British Columbia and currently employs 0 full-time employees. The company went IPO on 2006-08-01. Xenotransplantation is defined as the transplantation of organs, cells and tissues from one species to another. The firm has one reportable segment, which is the development of products to address the shortage of human donor cells and organs for transplantation into patients. All the Company’s activities are located in the United States. The firm intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.
Follow-Up Questions
Qui est le CEO de Xeno Aeronautics Corp ?
Elliot Lebowitz est le President de Xeno Aeronautics Corp, il a rejoint l'entreprise depuis 2007.
Quelle est la performance du prix de l'action XENO ?
Le prix actuel de XENO est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Xeno Aeronautics Corp ?
Xeno Aeronautics Corp appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Xeno Aeronautics Corp ?
La capitalisation boursière actuelle de Xeno Aeronautics Corp est de $0
